United States v. Martin

228 F.3d 1, 56 U.S.P.Q. (BNA) 1410, 2000 U.S. App. LEXIS 23918, 2000 WL 1376377
CourtCourt of Appeals for the First Circuit
DecidedSeptember 28, 2000
Docket00-1039
StatusPublished
Cited by78 cases

This text of 228 F.3d 1 (United States v. Martin) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Martin, 228 F.3d 1, 56 U.S.P.Q. (BNA) 1410, 2000 U.S. App. LEXIS 23918, 2000 WL 1376377 (1st Cir. 2000).

Opinion

*6 TORRUELLA, Chief Judge.

On September 16, 1998, a grand jury-returned a indictment charging Dr. Stephen R. Martin and Caryn L. Camp with ten counts of wire fraud, two counts of mail fraud, one count of conspiracy to steal trade secrets, one count of conspiracy to transport stolen goods, and one count of interstate transportation of stolen goods. Camp agreed to testify against Martin as part of a plea agreement. Martin proceeded to trial, where a jury found him not guilty on six counts of wire fraud (counts 1-6) and of interstate transportation of stolen goods (count 15). The jury found Martin guilty on the remaining counts of wire fraud (counts 7-10), mail fraud (counts 11-12), conspiracy to steal trade secrets (count 13), and conspiracy to transport stolen property in interstate commerce (count 14). This appeal, challenging the sufficiency of the evidence for conviction, followed.

For the reasons stated below, we affirm.

BACKGROUND

This case arises out of an electronic mail “pen-pal” relationship between a dissatisfied Maine chemist, Caryn Camp, and a California scientist, Dr. Stephen Martin.

I. Events Prior to May 1,1998

A.Camp’s Employment at IDEXX

Camp first began work at IDEXX, Inc. (“IDEXX”), a manufacturer of veterinary products headquartered in Portland, Maine, in May of 1995. Camp’s responsibilities as an IDEXX chemist included mixing chemicals for diagnostic test kits for both pets and livestock. At the time of her employment, she signed non-disclosure and non-competition agreements, promising in part not to “disclose to others, or use for [her] own benefit or the benefit of others, any of the Developments or any confidential, proprietary or secret information owned, possessed or used by [IDEXX] or its customers or contractors.” The proprietary information included, but was not limited to, “trade secrets, processes, data, know-how, marketing plans, forecasts, unpublished financial statements, budgets, licenses, prices, costs, and employee, customer and supplier lists.” Camp also signed the IDEXX policy on ethics and business conduct, which prohibited employees from revealing “proprietary knowledge or data” without prior authorization.

B. Martin’s Communication with IDEXX

In May 1997, Martin, as CEO of Wyoming DNA Vaccine (“WDV”), contacted IDEXX with a proposal involving research into human immunodeficiency virus (HIV) and feline immunodeficiency virus (FIV). Although IDEXX ultimately rejected Martin’s proposal, he signed a confidentiality agreement during his conversations with IDEXX.

C. Camp’s Initial Contact with Martin

By early 1998, Camp was dissatisfied and bored with her job. In January 1998, she began researching other potential job opportunities. She found the Internet web site for WDV and sent an electronic mail message with an attached resumé. Martin responded immediately via electronic mail, praising Camp’s credentials and touting the beauty of Cody, Wyoming (the future site of WDV). Martin also noted the existence of the WDV-IDEXX confidentiality agreement and the fact that WDV had chosen to “develop [its] own program ... with respect to veterinary diagnostics.” After receiving Martin’s response, Camp sent Martin a letter providing more detail about her qualifications.

Between January and March of 1998, Martin and Camp continued their correspondence. Based partly on Martin’s encouragement and partly on her own interests, Camp contacted the Director of Regulatory Affairs at IDEXX and obtained permission to “volunteer [her] free time” to learn that end of the business. *7 Martin indicated that despite Camp’s preference for laboratory work, she would be more useful to WDV for her regulatory experience and knowledge. Martin briefed Camp on his own work at WDV, while Camp continued to update Martin on her professional success, in particular her promotion to a technical position in IDEXX’s Livestock/Poultry unit.

Camp and Martin’s early correspondence established several themes that would permeate their e-mails: contained within the small talk was on-going discussion of Camp’s future employment with Martin’s company, as well as a willingness by Camp to relay IDEXX information and gossip to Martin. Camp described her promotion as preparation “for making a strong contribution to the success of WDV” within four to six months. Her February 27 letter contained information regarding a manual that “Idexx ... [is] not exactly supposed to have.” And throughout this period, Camp’s correspondence included light-hearted remarks about the weather, life in Maine, and a potential future in Wyoming.

D. “Pen-Pals”

Camp and Martin’s correspondence became more and more frequent during March and April of 1998. Camp continued to apprise Martin of her problems with IDEXX management, the changes associated with her new position in technical support, and her interest in new employment, both at WDV and elsewhere. At times she included information about IDEXX’s internal strategic weaknesses and customer complaints. Camp noted in an April 12 e-mail that the information she had transmitted was to some extent confidential. Martin reciprocated the information exchange: he told Camp about conflicts within WDV that ultimately resulted in his formation of a separate company called “Maverck”; he also relayed “confidential” WDV information. Martin continued to discuss Camp’s future, noting that she could “have a job with either [WDV or Maverck],” that he thought she “belonged] in Tahoe/Reno,” and that she might “become CEO [her]self one day.”

As the two corresponded more frequently, their communications became more personal. Camp began to refer to Martin as “Steve.” They discussed their families and social lives, and even shared the messages with family members. As their relationship grew more personal, both Camp and Martin, but particularly Martin, spoke jokingly of the “spy” aspect of the correspondence. For example, Martin referred to Camp’s gossip as “IDEXX Files” and described the events at WDV as a “palace coup.” Martin also continued to praise Camp’s “aggressiveness” and exhorted her to work only in her own interest and to continue to accumulate relevant knowledge.

On April 14, Martin indicated that he “had much to tell” Camp, but that he wanted her to sign a confidentiality agreement first. Camp considered signing the agreement immediately, but ultimately postponed signing because of potential ethical concerns, including potential competition between WDV and IDEXX. 1

On April 22, Camp sent Martin an email discussing the poultry and livestock industries, noting problems IDEXX customers had been having with particular diagnostic kits, and mentioning that customers “loved” the IDEXX free software program “x-Chek.” Camp continued to discuss IDEXX’s poor customer service approach in her May 1 “travelogue,” written during a business trip to the Midwest. Throughout her “travelogue,” Camp repeatedly expressed her happiness in being away from IDEXX and her willingness to move on to new employment.

*8 II. Events Between May 1, 1998 and July 18,1998

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Yu
First Circuit, 2025
Dahlstrom v. Biden
W.D. Washington, 2025
United States v. Condron
98 F.4th 1 (First Circuit, 2024)
United States v. Buoi
84 F.4th 31 (First Circuit, 2023)
Azurity Pharmaceuticals, Inc. v. Edge Pharma, LLC
45 F.4th 479 (First Circuit, 2022)
Webster v. Gray
39 F.4th 27 (First Circuit, 2022)
United States v. Guerrero-Narvaez
29 F.4th 1 (First Circuit, 2022)
United States v. Lopez-Martinez
994 F.3d 1 (First Circuit, 2021)
United States v. Shan Shi
991 F.3d 198 (D.C. Circuit, 2021)
Daviscourt v. United States
W.D. Washington, 2021

Cite This Page — Counsel Stack

Bluebook (online)
228 F.3d 1, 56 U.S.P.Q. (BNA) 1410, 2000 U.S. App. LEXIS 23918, 2000 WL 1376377, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-martin-ca1-2000.